Factors
Anti-HBs after 1st booster dose
X
2
P
No. examined
< 10 mIU/ml
> 10 mIU/ml
No.
%
No.
%
Age (years)
-
0.303Δ
10-
9
1
11.1
8
88.9
12-
17
1
5.9
16
94.1
14-
6
1
16.7
5
83.3
16-17
13
4
30.8
9
69.2
Mean ± SD
14.1 ± 2.6
13.5 ± 2.2
t=1.1 P=0.280
Gender
-
0.103Δ
Male
26
6
23.1
20
76.9
Female
19
1
5.3
18
94.7
BMI
1.147
0.766
Underweight
2
0
0.0
2
100.0
Normal R
32
5
15.6
27
84.4
Overweight
8
1
12.5
7
87.5
Obese
3
1
33.3
2
66.7
Mean ± SD
24.4 ± 5.9
19.8 ± 3.3
t = 3.283 P=0.001*
Duration ofDM
<2
10
2
20.0
8
80.0
0.400
0.940
2-
11
2
18.2
9
81.8
4-
15
2
13.3
13
86.7
7-12
9
1
11.1
8
88.9
Mean ± SD
3.1 ± 4.5
4.5 ± 3.3
t=-1.015 P=0.316
Insulin dose
< 30
8
1
12.5
7
87.5
-
0.936 Δ
30-
14
2
14.3
12
85.7
40+
28
4
17.4
19
82.6
Mean ± SD
50.7 ± 23.5
40.9 ± 15.9
t=1.4 P=0.173
HBA1c
-
0.118 Δ
Less than 7
20
5
25.0
15
75.0
More than 7
25
2
8.0
23
92.0
Complications ofDM
0.773
0.379
No
42
6
14.3
36
85.7
yes
3
1
33.3
2
66.7
Hospitalization
8.198
0.017*
No
18
1
5.6
17
94.4
Once
14
1
7.1
13
92.9
Frequent
12
5
41.7
7
58.3
Anti-HBc
0.809
0.368
Negative
41
7
17.1
34
82.9
Positive
4
0
0.0
4
100.0
Anti-HCV
0.188
0.664
Negative
44
7
15.9
37
84.1
Positive
1
0
0.0
1
100.0
Table 5:
Factors affecting the immune response to 1st boosting among diabetics. *P<0.05 (significant), Δ: P value based on Mont Carlo exact probability, DM: Diabetes Mellitus.
